- Reaction score
- 1,332
Because we have a good sample size that shows that dermarolling isn't very effective treatment, at least on it's own.
You can't call this guy an outlier because you don't have large enough sample size to go by. If a lot of people came out and reported no results, then id agree with you.
Let's not kid ourselves. From the "self-experimentation" community hundreds of people have tried DP2 antagonists already. It all started back in 2012 with the likes of OC459 and TM30089. And don't come up that setipiprant is different. Yes well, it is different actually... It has weaker affinity and a lower residence time towards the DP2 receptor. And even when we look at setipiprant many people have tried this stuff already from different sources. And if it were to be anywhere close to finasteride or people would have cosmetic improvement from the stuff the forums would be full of it already. Silence speaks for itself.
Way more importantly perhaps you don't understand this but often case reports are released if hair related changes are seen due to a treatment/drug or whatever. I'll give you two quick examples but I could give you many more;
http://www.clinicaloncologyonline.net/article/S0936-6555(05)00194-9/abstract
We report an interesting case of new hair growth after gefitinib treatment. A 57-year-old man with androgenic alopecia first presented with back pain in January 2004.
Other case:
http://www.ncbi.nlm.nih.gov/m/pubmed/24153140/?i=6&from=hair loss 2013
We report the case of a 64-year-old man with androgenetic alopecia who was started on methotrexate therapy for treatment of psoriasis after traditional modalities failed. Following treatment with methotrexate, he noted hair regrowth on the scalp.
I have written a post about this and gave many other examples. But, hey how strange is that huh, firstpost? People actually do notice if their scalp hair changes! Hair related changes can be seen through your own eyes man! How cool is that! You know that is how minoxidil and PGF2A got discovered for hair growth? Now do you know how many people have gone through clinical trials with molecules that target DP2? Hundreds, even for a long amount of time (6 months and longer)! Yes, there are probably 10 compounds or something running clinical trials right now. Obviously setipiprant got left behind because it's a goddamn weak molecule as described in studies which I can provide you too.
And guess what dude!? No patient or someone close to him, no investigator or anyone apparently noted hair growth changes in these trials? Hair related changes due to EGFR inhibitors like with the 57 year old man are for instance well reported and documented with several case studies. Here man another one that came out recently; http://erj.ersjournals.com/content/46/suppl_59/PA4293.abstract.
Here, we report two cases of NSCLC who have exhibited overt hair growth after initiating treatment with gefitinib. Both cases were male, and had stage IV adenocarcinoma with an in-frame deletion in exon 19 of the EGFR gene. Gefitinib was administered as the first-line chemotherapy, and has achieved complete remission in both cases. Besides the skin rashes, Case 1 experienced hair growth in scalp with more solid, abundant, and much blacker characteristics after several months of treatment. Case 2 noted new hair growth in a previously bald area on the top scalp after four months of gefitinib administration.
Google is furthermore your best friend..
Now tell me firstpost how come out of hundreds of people there are no such events documented of DP2 antagonists? Not even one!!! I guess they would keep such things a secret huh, quick put your tinfoil hat on!
But firstpost you can always come back if you have proper evidence.. Now I'm leaving this topic if you don't mind because I don't want to hijack it from OP. Kisses, firstpost.